| Literature DB >> 28119762 |
T Beena1, L Sudha1, A Nataraj1, V Balachandran2, D Kannan3, M N Ponnuswamy4.
Abstract
BACKGROUND: Coumarin (2H-chromen-2-one) and its derivatives have a wide range of biological and pharmaceutical activities. They possess antitumor, anti-HIV, anticoagulant, antimicrobial, antioxidant, and anti-inflammatory activities. Synthesis and isolation of coumarins from different species have attracted the attention of medicinal chemists. Herein, we report the synthesis, molecular structure, dielectric, anticancer activity and docking studies with the potential target protein tankyrase.Entities:
Keywords: Anti-cancer activity; Chromen; DFT; Dielectric studies; Molecular docking
Year: 2017 PMID: 28119762 PMCID: PMC5225380 DOI: 10.1186/s13065-016-0230-8
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Scheme 1Reaction scheme showing the synthesis of the compound (MBDC)
Fig. 1Optimized molecular structure and atomic numbering of MBDC
Optimized geometrical parameters of (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one at B3LYP/6-31 + G(d,p) level of theory
| Bond length | Value (Å) | Expt.a | Bond angle | Value (°) | Expt.a |
|---|---|---|---|---|---|
| C1–C2 | 1.411 | 1.407 (15) | C2–C1–C6 | 117.36 | 118.8 (14) |
| C1–C6 | 1.408 | C6–C1–C7 | 124.68 | 124.0 (15) | |
| C1–C7 | 1.464 | 1.456 (14) | C1–C2–H31 | 121.38 | 120.2 (15) |
| C2–C3 | 1.390 | 1.378 (14) | C3–C2–H18 | 119.56 | 119.0 (14) |
| C2–H18 | 1.086 | 0.950 (15) | C2–C3–C4 | 121.06 | 121.5 (15) |
| C3–C4 | 1.404 | 1.378 (14) | C3–C4–C5 | 117.74 | 117.3 (15) |
| C3–H19 | 1.087 | 0.990 (15) | C3–C4–C20 | 120.92 | 120.3 (15) |
| C4–C5 | 1.401 | 1.403 (15) | C5–C6–H25 | 118.79 | 119.8 (15) |
| C4–C20 | 1.509 | 1.499 (14) | C1–C7–C8 | 130.11 | 131.9 (14) |
| C5–C6 | 1.394 | 1.389 (14) | C8–C7–H26 | 114.99 | |
| C5–H24 | 1.087 | 0.990 (15) | C7–C8–C13 | 115.44 | 116.8 (14) |
| C6–H25 | 1.083 | C7–C8–C9 | 126.11 | 125.5 (14) | |
| C7–C8 | 1.355 | C8–C9–C10 | 112.38 | ||
| C7–H26 | 1.088 | 0.950 (15) | C8–C9–H28 | 109.63 | |
| C8–C9 | 1.511 | C8–C9–H29 | 108.74 | ||
| C8–C13 | 1.491 | 1.491 (14) | H28–C9–H29 | 106.06 | 107.2 (15) |
| C9–C10 | 1.509 | C9–C10–C11 | 119.35 | ||
| C9–H28 | 1.102 | C9–C10–C14 | 122.68 | ||
| C10–C11 | 1.394 | C8–C13–O27 | 125.15 | ||
| C10–C14 | 1.400 | C10–C14–H30 | 118.76 | ||
| C11–O12 | 1.387 | O12–C11–C17 | 116.22 | 116.6 (15) | |
| C11–C17 | 1.395 | C9–C8–C13 | 118.44 | 118.96 (14) | |
| O12–C13 | 1.376 | C11–C10–C14 | 117.93 | ||
| C13=O27 | 1.211 | 1.261 (15) | C1–C7–H26 | 114.86 | |
| C14–H30 | 1.087 | C1–C6–C5 | 120.92 | 120.7 (14) | |
| C15–C16 | 1.399 | C1–C6–H25 | 120.23 | ||
| C17–H33 | 1.084 | C2–C3–H19 | 119.40 | 119.8 (15) | |
| C10–C11–O12 | 121.79 | 120.8 (15) |
aX-ray data from Refs. [14] and [15]
Fig. 2a Experimental and b predicted FT-IR spectra of MBDC
Fig. 3a Experimental and b predicted FT-Raman spectra of MBDC
The observed FT-IR, FT-Raman and calculated frequencies (in cm−1) using B3LYP/6-31 + G (d,p) along with their relative intensities, probable assignments, reduced mass and force constants of (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one
| Mode nos | Observed frequencies (cm−1) | Calculated frequencies (cm−1) | Reduced mass (amu) | Force constant (mdyn/Å) | IR intensity (km/mol) | Raman intensity (Å4 amu−1) | Vibrational assignments (PED%) | ||
|---|---|---|---|---|---|---|---|---|---|
| FTIR | FT Raman | Unscaled | Scaled | ||||||
| 1 | 23 | 20 | 4.139 | 0.001 | 0.140 | 98.862 | τ Ring (56), τ CH3 (20) | ||
| 2 | 30 | 36 | 29 | 1.041 | 0.001 | 0.259 | 2.839 | τ Ring (56), τ CH3 (20) | |
| 3 | 43 | 48 | 42 | 4.317 | 0.006 | 0.138 | 4.698 | τ Ring (55), τ CH3 (18) | |
| 4 | 60 | 61 | 60 | 4.037 | 0.009 | 0.126 | 4.758 | τ Ring (56), τ CH3 (20) | |
| 5 | 81 | 78 | 6.433 | 0.025 | 1.029 | 1.382 | τ Ring (55), τ CH3 (22) | ||
| 6 | 101 | 96 | 4.785 | 0.029 | 0.456 | 0.906 | γ C=O (58), τ CH3 (21) | ||
| 7 | 156 | 143 | 4.419 | 0.064 | 1.546 | 0.321 | τ CH3 (56) | ||
| 8 | 189 | 181 | 3.393 | 0.072 | 0.402 | 1.098 | τ CH2 (56), γ CH3 (18) | ||
| 9 | 200 | 225 | 202 | 6.604 | 0.197 | 2.382 | 0.235 | γ C–CH3 (54), γ CH (18), γ CH3 (12) | |
| 10 | 252 | 237 | 4.366 | 0.164 | 1.529 | 0.314 | γ CC (62), γ CH (20), γ CH2 (10) | ||
| 11 | 274 | 255 | 4.050 | 0.179 | 1.403 | 0.314 | γ CCC (60), γ CH (22), γ CH3 (11) | ||
| 12 | 314 | 286 | 4.114 | 0.240 | 0.632 | 0.065 | γ CCC (59), γ CH (18), γ CH3 (10) | ||
| 13 | 327 | 309 | 5.288 | 0.335 | 1.339 | 0.029 | γ CCC (58), γ CH (18), γ CH3 (11) | ||
| 14 | 350 | 368 | 354 | 3.122 | 0.249 | 0.038 | 0.119 | γ CCC (60), γ CH (22), γ CH3 (12) | |
| 15 | 400 | 409 | 400 | 3.550 | 0.350 | 1.104 | 0.482 | γ CCC (62), γ CH (18), γ CH3 (10) | |
| 16 | 421 | 413 | 2.977 | 0.310 | 1.829 | 0.326 | γ CCC (62), γ CH (20), γ CH3 (10) | ||
| 17 | 444 | 437 | 4.136 | 0.482 | 3.120 | 0.773 | γ CCC (62), γ CH (20), γ CH3 (11) | ||
| 18 | 450 | 457 | 453 | 4.033 | 0.496 | 3.817 | 0.144 | γ CCC (63), γ CH (18), γ CH3 (12) | |
| 19 | 490 | 479 | 5.515 | 0.783 | 24.603 | 0.378 | βC=O (58), βCC (22), βCO (10) | ||
| 20 | 500 | 524 | 506 | 2.790 | 0.452 | 12.486 | 0.794 | γ C–O (64), γ CH3 (23), γ CO (10) | |
| 21 | 540 | 527 | 5.569 | 0.786 | 5.539 | 0.239 | γ CH (58), γ CH3 (22), γ CC (10) | ||
| 22 | 540 | 545 | 540 | 3.662 | 0.642 | 4.599 | 0.033 | γ CH (58), γ CC (21), γ CH2 (11) | |
| 23 | 575 | 582 | 572 | 6.588 | 1.319 | 2.309 | 0.138 | γ CH (58), γ CH3 (20), γ CC (11) | |
| 24 | 600 | 639 | 601 | 6.329 | 1.526 | 7.519 | 0.104 | γ CH (56), γ CC (20), γ CH3 (10) | |
| 25 | 650 | 633 | 6.834 | 1.703 | 0.662 | 0.176 | γ CH (58), γ CC (18), γ CH2 (11) | ||
| 26 | 693 | 669 | 5.112 | 1.447 | 4.947 | 0.007 | γ CH (56), γ CH3 (18), γ CC (12) | ||
| 27 | 711 | 689 | 3.832 | 1.142 | 0.262 | 0.116 | γ CH (56), γ CC (16) | ||
| 28 | 727 | 716 | 3.876 | 1.208 | 9.921 | 0.085 | γ CH (56), γ CC (18) | ||
| 29 | 725 | 737 | 723 | 5.549 | 1.776 | 11.299 | 0.128 | γ CH (58), γ CC (18) | |
| 30 | 740 | 735 | 4.346 | 1.404 | 0.599 | 0.184 | βC–CH3 (60), βCH (23) | ||
| 31 | 750 | 768 | 748 | 1.335 | 0.465 | 62.541 | 0.034 | βC–O (62), βCC (22) | |
| 32 | 778 | 760 | 4.144 | 1.481 | 7.458 | 0.587 | βCC (58), βCH (21), βCH3 (10) | ||
| 33 | 810 | 829 | 811 | 1.610 | 0.653 | 37.872 | 0.230 | βCCC (63), βCH (21), βCH3 (12) | |
| 34 | 851 | 824 | 1.26 | 0.540 | 0.813 | 0.119 | βCCC (63), βCH (18), βCH3 (11) | ||
| 35 | 858 | 830 | 3.739 | 1.625 | 14.149 | 0.099 | βCCC (62), βCH3 (20), βCH (10) | ||
| 36 | 862 | 838 | 2.202 | 0.964 | 0.532 | 0.221 | βCCC (62), βCH3 (21), βCH (12) | ||
| 37 | 850 | 876 | 850 | 1.962 | 0.888 | 3.587 | 0.199 | βCCC (56), βCH (18), βCH3 (10) | |
| 38 | 919 | 861 | 6.652 | 3.314 | 11.953 | 0.057 | βCCC (58), βCH3 (18), βCH (12) | ||
| 39 | 947 | 869 | 1.572 | 0.831 | 5.009 | 0.061 | βCCC (56), βCH (16), βCH3 (11) | ||
| 40 | 875 | 954 | 872 | 1.399 | 0.751 | 11.534 | 1.087 | βCCC (61), βCH (20), βCH3 (10) | |
| 41 | 970 | 889 | 1.579 | 0.877 | 5.474 | 0.037 | βCH (78), ν CC (18) | ||
| 42 | 900 | 981 | 903 | 1.476 | 0.837 | 5.323 | 0.410 | βCH (76), ν CC (16) | |
| 43 | 984 | 923 | 1.377 | 0.786 | 2.738 | 0.150 | βCH (78), ν CC (13) | ||
| 44 | 988 | 951 | 1.282 | 0.738 | 0.051 | 0.002 | βCH (66), ν CC (16) | ||
| 45 | 1010 | 968 | 1.409 | 0.848 | 2.809 | 0.020 | βCH (66), ν CC (20) | ||
| 46 | 990 | 1033 | 992 | 2.848 | 1.794 | 2.530 | 0.024 | βCH (70), ν CC (18) | |
| 47 | 1056 | 1011 | 2.122 | 1.396 | 3.275 | 0.289 | βCH (76), ν CC (18) | ||
| 48 | 1060 | 1029 | 1.545 | 1.024 | 11.399 | 0.009 | βCH (78), ν CC (17) | ||
| 49 | 1088 | 1042 | 4.259 | 2.975 | 171.99 | 0.044 | βCH (78), ν CC (17) | ||
| 50 | 1000 | 1133 | 1053 | 1.775 | 1.344 | 19.980 | 0.028 | βCH2ipr (67), βCH (20) | |
| 51 | 1148 | 1061 | 1.367 | 1.063 | 20.088 | 0.106 | γ CH2opr (66), βCH (21) | ||
| 52 | 1075 | 1180 | 1072 | 1.113 | 0.914 | 4.889 | 0.005 | βCH3ipr (65), βCC (30) | |
| 53 | 1100 | 1190 | 1104 | 2.389 | 1.994 | 564.050 | 3.029 | γ CH3opr (71), βCC (23) | |
| 54 | 1150 | 1215 | 1153 | 1.274 | 1.109 | 16.185 | 0.942 | ν CO (58), βCH (18), ν CC (11) | |
| 55 | 1189 | 1218 | 1190 | 1.580 | 1.381 | 27.443 | 0.044 | ν CO (58), βCH (18), ν CC (12) | |
| 56 | 1227 | 1197 | 2.167 | 1.924 | 37.004 | 1.290 | ν C=C (82), βCH3 (14) | ||
| 57 | 1238 | 1209 | 2.485 | 2.247 | 7.534 | 0.045 | ν CC (71), βCH (16), ν CH3 (12) | ||
| 58 | 1255 | 1217 | 2.115 | 1.964 | 33.951 | 0.281 | ν C–CH3 (50), βCH (20), βCO (12) | ||
| 59 | 1215 | 1258 | 1231 | 3.099 | 2.893 | 219.799 | 0.644 | βCH2sb (66), βCC (22), βCH (11) | |
| 60 | 1288 | 1243 | 1.825 | 1.785 | 19.982 | 0.588 | βCH2asb (70), βCC (20), βCH (10) | ||
| 61 | 1250 | 1340 | 1250 | 5.462 | 5.782 | 49.937 | 0.759 | βCH3sb (71), βCC (23), βCH (11) | |
| 62 | 1261 | 1342 | 1260 | 1.625 | 1.727 | 2.543 | 0.527 | βCH3asb (66), βCH (17), ν CC (10) | |
| 63 | 1349 | 1287 | 2.373 | 2.544 | 13.033 | 0.436 | βCH3asb (60), βCH (18), ν CC (10) | ||
| 64 | 1369 | 1306 | 2.450 | 2.709 | 31.517 | 0.047 | ν CC (68), βCH (18) | ||
| 65 | 1407 | 1330 | 1.776 | 2.074 | 9.480 | 0.143 | ν CC (66), βCH (19) | ||
| 66 | 1420 | 1343 | 1.248 | 1.483 | 0.324 | 0.393 | ν CC (66), βCH (18) | ||
| 67 | 1440 | 1362 | 2.310 | 2.850 | 7.463 | 0.084 | ν CC (68), βCH (19) | ||
| 68 | 1476 | 1387 | 1.277 | 1.449 | 12.963 | 0.069 | ν CC (68), βCH (19) | ||
| 69 | 1491 | 1395 | 1.072 | 1.450 | 11.786 | 0.102 | ν CC (70), βCH (18) | ||
| 70 | 1492 | 1404 | 2.295 | 3.013 | 30.676 | 0.013 | ν CC (70), βCH (17) | ||
| 71 | 1432 | 1496 | 1430 | 1.114 | 1.469 | 9.704 | 0.119 | ν CC (68), βCH (17) | |
| 72 | 1529 | 1487 | 2.593 | 3.574 | 57.049 | 0.019 | ν CC (66), βCH (18) | ||
| 73 | 1500 | 1548 | 1502 | 2.482 | 3.505 | 23.043 | 0.262 | ν CC (65), βCH (18) | |
| 74 | 1540 | 1603 | 1543 | 5.415 | 8.200 | 5.106 | 0.867 | ν CC (66), βCH (19) | |
| 75 | 1636 | 1587 | 6.310 | 9.958 | 21.097 | 0.660 | ν CC (65), βCH (18) | ||
| 76 | 1654 | 1592 | 6.049 | 9.754 | 145.323 | 3.229 | ν CC (66), βCH (18) | ||
| 77 | 1659 | 1604 | 6.840 | 11.109 | 9.718 | 0.093 | ν CC (68), βCH (18) | ||
| 78 | 1600 | 1668 | 1615 | 7.222 | 11.846 | 91.204 | 0.131 | ν CC (70), βCH (16) | |
| 79 | 1616 | 1690 | 1793 | 1692 | 12.541 | 23.775 | 370.738 | 0.460 | ν C=O (72), ν CC (14) |
| 80 | 2980 | 2801 | 1.072 | 5.615 | 14.012 | 0.299 | ν ssCH2 (80) | ||
| 81 | 2800 | 3034 | 2809 | 1.039 | 5.641 | 33.955 | 0.722 | ν assCH2 (82) | |
| 82 | 3080 | 2863 | 1.088 | 6.085 | 4.273 | 0.081 | ν ssCH3 (72), ν CH (23) | ||
| 83 | 3092 | 2889 | 1.097 | 6.182 | 17.402 | 0.180 | ν assCH3 (80), ν CH (16) | ||
| 84 | 3122 | 2911 | 1.102 | 6.330 | 15.019 | 0.127 | ν assCH3 (88), ν CH (11) | ||
| 85 | 3172 | 2936 | 1.088 | 6.451 | 3.815 | 0.088 | ν CH (96) | ||
| 86 | 3175 | 2945 | 1.088 | 6.464 | 5.999 | 0.065 | ν CH (96) | ||
| 87 | 3177 | 2962 | 1.088 | 6.464 | 7012 | 0.109 | ν CH (96) | ||
| 88 | 3179 | 2989 | 1.089 | 6.488 | 17.412 | 0.127 | ν CH (98) | ||
| 89 | 3192 | 2993 | 1.089 | 6.536 | 7.580 | 0.129 | ν CH (98) | ||
| 90 | 3193 | 2999 | 1.094 | 6.574 | 14.859 | 0.219 | ν CH (96) | ||
| 91 | 3206 | 3007 | 1.094 | 6.629 | 18.471 | 0.243 | ν CH (98) | ||
| 92 | 3020 | 3218 | 3018 | 1.096 | 6.687 | 5.949 | 0.335 | ν CH (98) | |
| 93 | 3100 | 3225 | 3101 | 1.091 | 6.690 | 6.782 | 0.076 | ν CH (98) | |
ν, stretching; β, in plane bending; γ, out of plane bending; ω, wagging; τ, torsion; ρ, rocking; δ, scissoring; ss, symmetric stretching; ass, antisymmetric stretching; sb, symmetric bending; asb, antisymmetric bending; ipr, in-plane-rocking; opr, out-of-plane rocking
Fig. 4The calculated frontiers energies of MBDC
Second-order perturbation energy [E(2), kcal/mol] between donor and acceptor orbitals of MBDC calculated at B3LYP/6-31 + G(d,p) level of DFT theory
| Donor (i) | Acceptor (j) | E(2) | ED (i) (e) | ED (j)(e) | E(j) − E(i) (a.u.) | F(i,j) (a.u.) |
|---|---|---|---|---|---|---|
| LP(1)O27 | σ*C8–C13 | 3.01 | 1.97789 | 0.07355 | 1.11 | 0.052 |
| LP(1)O27 | σ*C13–O12 | 0.08 | 1.97789 | 0.10629 | 1.03 | 0.026 |
| LP(2)O27 | π*C8–C13 | 18.58 | 1.83804 | 0.07355 | 0.67 | 0.102 |
| LP(2)O27 | π*C13–O12 | 35.64 | 1.83804 | 0.10629 | 0.60 | 0.132 |
| LP(2)O27 | π*C7–H26 | 0.70 | 1.83804 | 0.01944 | 0.73 | 0.021 |
| LP(1)O12 | σ*C8–C13 | 6.30 | 1.95794 | 0.07355 | 0.96 | 0.070 |
| LP(1)O12 | σ*C10–C11 | 6.54 | 1.95794 | 0.03331 | 1.11 | 0.076 |
| LP(1)O12 | σ*C11–C17 | 0.77 | 1.95794 | 0.02024 | 1.10 | 0.026 |
| LP(1)O12 | σ*C13–O27 | 2.06 | 1.95794 | 0.01348 | 1.16 | 0.044 |
| LP(2)O12 | σ*C10–C11 | 25.17 | 1.95794 | 0.38783 | 0.36 | 0.088 |
| LP(2)O12 | σ*C13–O27 | 41.74 | 1.76210 | 0.24560 | 0.34 | 0.106 |
| σC8–C9 | σ*C8–C7 | 3.21 | 1.9767 | 0.01864 | 1.29 | 0.057 |
| σC8–C13 | σ*C7–C1 | 4.13 | 1.97727 | 0.02282 | 1.14 | 0.061 |
| πC9–H28 | π*C8–C7 | 3.36 | 1.96228 | 0.06368 | 0.55 | 0.038 |
| πC9–H29 | π*C10–C11 | 3.31 | 1.96216 | 0.38783 | 0.53 | 0.041 |
| σC10–C14 | σ*C11–O12 | 4.82 | 1.97139 | 0.03516 | 1.03 | 0.063 |
| σC11–C17 | σ*C10–C11 | 4.15 | 1.97581 | 0.03331 | 1.28 | 0.065 |
| σH30–C14 | σ*C10–C11 | 4.18 | 1.98112 | 0.03331 | 1.10 | 0.061 |
| σC17–C16 | σ*C11–O12 | 4.34 | 1.97651 | 0.03516 | 1.03 | 0.060 |
| σC17–H33 | σ*C10–C11 | 4.56 | 1.97906 | 0.03331 | 1.09 | 0.063 |
| σC7–H26 | σ*C8–C9 | 7.24 | 1.96715 | 0.02414 | 0.94 | 0.074 |
| σC2–H18 | σ*C1–C6 | 4.35 | 1.98162 | 0.02521 | 1.08 | 0.061 |
| σC6–H25 | σ*C1–C2 | 4.31 | 1.98170 | 0.02470 | 1.09 | 0.061 |
| σC5–H24 | σ*C6–C4 | 4.24 | 1.98119 | 0.02266 | 1.00 | 0.029 |
| πC20–H21 | π*C5–C4 | 4.04 | 1.98750 | 0.34063 | 0.53 | 0.045 |
NBO results showing the formation of Lewis and non Lewis orbitals of MBDC molecule by B3LYP/6-31G + (d,p) method
| Bond (A–B) | ED/energy (a.u.) | EDA % | EDB % | NBO | s % | p % |
|---|---|---|---|---|---|---|
| σ C8–C9 | 1.97667 | 50.31 | 49.69 | 0.7093 (sp2.03) | 32.95 | 67.02 |
| −0.65200 | ||||||
| σ C8–C13 | 1.97727 | 51.86 | 48.14 | 0.7201 (sp2.48) | 28.69 | 71.27 |
| −0.68595 | ||||||
| σ C9–H28 | 1.96228 | 63.78 | 36.22 | 0.7986 (sp3.34) | 23.04 | 76.91 |
| −0.51190 | ||||||
| σ C10–C14 | 1.97139 | 51.60 | 48.40 | 0.7184 (sp1.82) | 35.47 | 64.50 |
| −0.70409 | ||||||
| σ C11–C17 | 1.97581 | 51.16 | 48.84 | 0.7153 (sp1.62) | 38.17 | 61.80 |
| −0.71570 | ||||||
| σ H30–C14 | 1.98112 | 37.66 | 62.34 | 0.6137 (sp0.00) | 99.95 | 00.05 |
| −0.53074 | ||||||
| σ C17–C16 | 1.97651 | 50.46 | 49.54 | 0.7103 (sp1.79) | 35.85 | 64.11 |
| −0.25929 | ||||||
| σ C17–H33 | 1.97906 | 63.18 | 36.782 | 0.7948 (sp2.24) | 30.81 | 69.15 |
| −0.52986 | ||||||
| σ C7–H26 | 1.96715 | 63.87 | 36.13 | 0.7992 (sp2.36) | 29.74 | 70.22 |
| −0.52611 | ||||||
| σ C2–H18 | 1.98162 | 62.58 | 37.42 | 0.7911 (sp2.34) | 29.94 | 70.02 |
| −0.52927 | ||||||
| σ C6–H25 | 1.98170 | 62.53 | 37.47 | 0.7908 (sp2.34) | 29.93 | 70.03 |
| −0.53031 | ||||||
| σ C5–H24 | 1.98119 | 62.30 | 37.70 | 0.7893 (sp2.37) | 29.62 | 70.34 |
| −0.52761 | ||||||
| σ C20–H21 | 1.98750 | 62.42 | 37.58 | 0.7901 (sp3.12) | 24.25 | 75.70 |
| −0.51049 | ||||||
| LP(1) O27 | 1.97789 | sp0.70 | 58.63 | 41.30 | ||
| −0.69724 | ||||||
| LP(2) O27 | 1.83804 | sp99.99 | 00.05 | 99.66 | ||
| −0.26311 | ||||||
| LP(1) O12 | 1.95794 | sp1.89 | 34.56 | 65.38 | ||
| −0.54749 | ||||||
| LP(2) O12 | 1.76210 | sp1.00 | 00.00 | 99.88 | ||
| −0.33734 |
The charge distribution calculated by the Mulliken method
| Atoms | Mulliken charge | NBO |
|---|---|---|
| C1 | 0.35122 | −0.09783 |
| C2 | 0.07866 | −0.22079 |
| C3 | −0.25976 | −0.23196 |
| C4 | 0.28427 | −0.03843 |
| C5 | −0.54829 | −0.23334 |
| C6 | −0.26856 | −0.22441 |
| C7 | 0.10817 | −0.12331 |
| C8 | 0.48781 | −0.15456 |
| C9 | −0.49756 | −0.50908 |
| C10 | 0.90500 | −0.08766 |
| C11 | −0.95788 | 0.29617 |
| O12 | −0.39388 | −0.51439 |
| C13 | 0.33449 | 0.80701 |
| C14 | −0.31967 | −0.21966 |
| C15 | 0.13614 | −0.25219 |
| C16 | −0.08232 | −0.23483 |
| C17 | −0.15764 | −0.26075 |
| H18 | 0.13200 | 0.24986 |
| H19 | 0.12586 | 0.24422 |
| C20 | −0.60604 | −0.70947 |
| H21 | 0.17095 | 0.24897 |
| H22 | 0.16101 | 0.24929 |
| H23 | 0.15358 | 0.25629 |
| H24 | 0.12235 | 0.24404 |
| H25 | 0.12453 | 0.24877 |
| H26 | 0.15765 | 0.27521 |
| O27 | −0.44633 | −0.56839 |
| H28 | 0.18552 | 0.27671 |
| H29 | 0.16406 | 0.27813 |
| H30 | 0.12443 | 0.24480 |
| H31 | 0.12660 | 0.24891 |
| H32 | 0.13021 | 0.25025 |
| H33 | 0.14289 | 0.26243 |
UV-Vis excitation energy and electronic absorption spectra of MBDC using TD-B3LYP/631G + (d,p) method
| Exp. (nm) | Wavelength (nm) | Energy (eV) | Oscillator strength (f) | Assignments |
|---|---|---|---|---|
| 283 | 296 | 2.2007 | 0.0134 | π → π* |
| 283 | 265 | 2.2684 | 0.002 | π → π* |
| 215 | 223 | 2.4147 | 0.0036 | σ − σ* |
Fig. 5Experimental UV spectrum of MBDC. Inset figure predicated MEP map of MBDC
The calculated electric dipole moment (μtot D) the average polarizability (αtot × 10−24 esu) and the first hyperpolarizability (βtot × 10−31 esu)
| Parameters | Values |
|---|---|
| μx | 2.9237 |
| μy | −4.6995 |
| μz | −0.2541 |
| μtot (D) | 5.5406 |
| αxx | −93.6767 |
| αxy | 6.1433 |
| αyy | −119.8535 |
| αxz | −0.1725 |
| αyz | −4.4825 |
| αzz | −111.9369 |
| αtot (esu) | 2.32632 × 10 |
| βxxx | 23.1945 |
| βxxy | −28.7842 |
| βxyy | 20.1351 |
| βyyy | −51.2342 |
| βxxz | −32.9779 |
| βxyz | −12.6553 |
| βyyz | −7.0618 |
| βxzz | 5.9903 |
| βyzz | 8.6308 |
| βzzz | 6.4779 |
| βtot (esu) | 5.6583 × 10−31 |
Values of dielectric constant (ε0, ε′, ε∞) and relaxation time τ(ps) of MBDC in ethanol at 303 K
| System | Mole conc. | Static dielectric constant (ε0) | Microwave dielectric constant (ε′) | Optical dielectric constant (ε∞) | Relaxation time τ (ps) |
|---|---|---|---|---|---|
| Ethanol + MBDC | 0.025 | 24.10 | 22.45 | 1.848 | 125.45 |
| 0.040 | 21.14 | 20.33 | 1.945 | 132.61 | |
| 0.055 | 19.36 | 18.39 | 2.570 | 148.44 | |
| 0.070 | 15.89 | 16.59 | 2.832 | 153.89 |
Experimental (in CDCl3), predicted (δpred) 13C and 1H chemical shifts (ppm) and calculated GIAO/B3LYP/6-31 + G(d,p) isotropic magnetic shielding tensors (σcalc) for (3E)-3-(4-methylbenzylidene)-3,4-dihydro-2H-chromen-2-one
| 1H | δexp (CDCl3) | CDCl3 | Gas phase | 13C | CDCl3 | Gas phase | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| δpred | σcalc | δpred | σcalc | δpred | σcalc | δpred | σcalc | |||
| H18 | 7.36 | 7.42 | 23.9144 | 7.20 | 24.1513 | C1 | 115.85 | 62.9668 | 116.66 | 62.1766 |
| H19 | 7.36 | 7.46 | 23.8777 | 7.22 | 24.1263 | C2 | 117.49 | 61.3681 | 117.18 | 61.6766 |
| H21 | 2.42 | 2.66 | 28.8984 | 2.63 | 28.9317 | C3 | 111.81 | 66.8779 | 111.47 | 67.2105 |
| H22 | 2.42 | 2.39 | 29.1857 | 2.34 | 29.2393 | C4 | 127.41 | 51.7495 | 125.56 | 53.5485 |
| H23 | 2.42 | 2.21 | 29.3704 | 2.14 | 29.4509 | C5 | 111.58 | 67.1015 | 111.27 | 67.4047 |
| H24 | 7.21 | 7.40 | 23.9349 | 7.15 | 24.2029 | C6 | 112.70 | 66.0193 | 112.14 | 66.5622 |
| H25 | 7.39 | 7.41 | 23.9272 | 7.24 | 24.1070 | C7 | 129.24 | 49.9746 | 127.65 | 51.5188 |
| H26 | 7.96 | 8.13 | 23.1789 | 8.01 | 23.3020 | C8 | 106.14 | 72.3815 | 106.55 | 71.98 |
| H28 | 4.07 | 4.08 | 27.4169 | 3.92 | 27.5850 | C9 | 15.45 | 160.332 | 16.03 | 159.7719 |
| H29 | 4.07 | 4.02 | 27.4732 | 3.92 | 27.5830 | C10 | 106.20 | 72.3198 | 104.77 | 73.708 |
| H30 | 7.24 | 7.25 | 24.0981 | 6.95 | 24.4081 | C11 | 134.84 | 44.5441 | 135.63 | 43.7844 |
| H32 | 7.28 | 7.33 | 24.0134 | 7.10 | 24.2574 | C13 | 149.18 | 30.6419 | 146.48 | 33.261 |
| H33 | 7.10 | 7.10 | 24.2534 | 6.93 | 24.4260 | C14 | 110.11 | 68.5299 | 109.42 | 69.2007 |
| C15 | 107.00 | 71.5493 | 105.72 | 72.7857 | ||||||
| C16 | 109.94 | 68.6951 | 109.65 | 68.9804 | ||||||
| C17 | 99.92 | 78.414 | 100.35 | 77.9959 | ||||||
Fig. 6Experimental 1H NMR spectrum of MBDC
Fig. 7a MBDC interacts with the amino acid in the active site of tankyrase, b anticancer drug Warfarin derivative interacts with the amino acid in the active site of tankyrase, c surface diagram showing MBDC fit into the active site of tankyrase
Hydrogen bond interactions of title compound and co-crystal ligand with amino acids at the active site of tankyrases
| Docking score | Glide energy (kcal/mol) | Hydrogen bonding interactions | ||
|---|---|---|---|---|
| Donor | Acceptor | Distance (Å) | ||
| MBDC | ||||
| −10.823 | −49.845 | N–H[GLY1032] | O | 2.91 |
| O–H[SER1068] | O | 3.17 | ||
| Warfarin | ||||
| −10.625 | −55.759 | NH[Tyr1060] | O | 2.0 |
| NH[Gly1032] | O | 2.1 | ||
| OH | O[Gly1032] | 2.0 | ||
| OH | N[His 1031] | 3.7 | ||
| N[His1031] | O | 3.3 | ||
| O[His1048] | O | 3.5 | ||
Fig. 8Graphical representation of MBDC molecule on a MCF-7 cell line and b HT-29 cell line
Fig. 9Graphical representation of Warfarin derivative on a MCF-7 cell line and b HT-29 cell line